Galapagos | Spese Operative



Operating Expenses Cambiamento Data
argenx SE USD 635.37M 62.66M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Biogen USD 2.01B 13.3M 2024-12
Genmab DKK 4.25B 812M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Incyte USD 847.73M 29.46M 2025-03
Merck EUR 4.22B 52M 2024-12
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 1.23B 1.31B 2024-06
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Galapagos Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.